Ipilimumab/pembrolizumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1909卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16593-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：306 / 306

相关论文

共 50 条

[21] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1887 (1) : 396 - 396
[22] Ipilimumab/pembrolizumabIleus: case report
Reactions Weekly, 2023, 1956 (1) : 287 - 287
[23] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2021, 1854 (1) : 199 - 199
[24] Ipilimumab/NivolumabMyocarditis: case report
Reactions Weekly, 2024, 2028 (1) : 253 - 253
[25] Ipilimumab/sargramostimDermatomyositis: case report
Reactions Weekly, 2016, 1603 (1) : 158 - 158
[26] Ipilimumab/nivolumabHepatitis: case report
Reactions Weekly, 2019, 1734 (1) : 292 - 292
[27] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1748 (1) : 266 - 266
[28] Ipilimumab/nivolumabVitiligo: case report
Reactions Weekly, 2019, 1769 (1) : 262 - 262
[29] Ipilimumab/nivolumabHypopituitarism : case report
Reactions Weekly, 2022, 1907 (1) : 267 - 267
[30] Ipilimumab/nivolumabPancytopenia: case report
Reactions Weekly, 2024, 2023 (1) : 212 - 212

← 1 2 3 4 5 →